02:00 PM EDT, 07/23/2025 (MT Newswires) -- Dr. Reddy's Laboratories (RDY) reported fiscal Q1 earnings Wednesday of $0.20 per diluted share, up from $0.19 a year earlier.

Analysts surveyed by FactSet expected $0.21.

Revenue for the quarter ended June 30 was $997 million, up from $895 million a year earlier.

Analysts polled by FactSet expected $1.01 billion.

Shares of Dr. Reddy's Laboratories were up 1.7% in recent trading.

Price: 14.65, Change: +0.24, Percent Change: +1.67